Article
Antisense oligonucleotide-mediated exon skipping for Duchenne muscular dystrophy: progress and challenges.
Current gene therapy - 1 Jun 2012
Arechavala-Gomeza Virginia, Anthony Karen, Morgan Jennifer, Muntoni Francesco
Abstract excerpt
Duchenne muscular dystrophy (DMD) is the most common childhood neuromuscular disorder. It is caused by mutations in the DMD gene that disrupt the open reading frame (ORF) preventing the production of functional dystrophin protein. The loss of dystrophin ultimately leads to the degeneration of muscle fibres, progressive weakness and premature death. Antisense oligonucleotides (AOs) targeted to splicing elements...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
